Doctors Urge Taiwan's NHI to Expand Oral Targeted Therapy Coverage to Adults with Plexiform Neurofibromas
NQ Score
3/100
N1 Content Completeness
4
AI Summary (NQ-processed)
On the first anniversary of NHI coverage for an oral targeted therapy, over 50 children and adolescents with plexiform neurofibromas in Taiwan have benefited. However, the medical community highlights that most adult patients are still denied access to this treatment. Citing the higher risk of tumors turning malignant in adulthood, the Taiwan Child Neurology Society and others are calling for the government to expand coverage to include adults.